Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.

Martora, Fabrizio; Picone, Vincenzo; Battista, Teresa; Fabbrocini, Gabriella; Marasca, Claudio

Martora, Fabrizio; Picone, Vincenzo; Battista, Teresa; Fabbrocini, Gabriella; Marasca, Claudio.

Martora F; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Picone V; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Battista T; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Marasca C; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.

Dermatol Ther ; 35(8): e15602, 2022 08.

Article in English | MEDLINE | ID: covidwho-1868640

Subject(s)

COVID-19; Exanthema; Pityriasis Rosea; COVID-19 Vaccines; Humans; Pityriasis Rosea/diagnosis; Pityriasis Rosea/etiology; Vaccination

Keywords

Covid-19; Pityriasis rosea; hidradenitis suppurativa; lichen planus; psoriasis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pityriasis Rosea / Exanthema / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15602

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google